Flolan 1,5 mg; forsyningsvanskelighed

Imported from official source

Announcement

Safety Classified by Officially

Markedsføringen af Flolan 1,5 mg pulver og solvens til infusionsvæske, opløsning fra GlaxoSmithKline Pharma A/S vil ophøre.

Produkt: Flolan 1,5 mg pulver og solvens til infusionsvæske, opløsning

Aktivt stof: Epoprostenol (epoprostenolnatrium)

Forventet periode: Fra slut december 2027

Yderligere information: Permanent markedsophør

This is an extract. The publication continues at the source.

Source: Lægemiddelstyrelsen.

Read the original at the source: https://laegemiddelstyrelsen.dk/da/godkendelse/kontrol-og-inspektion/mangel-paa-medicin/meddelelser-om-forsyning-af-medicin/human-2026/flolan-1,5-mg-forsyningsvanskelighed/

Officially imported this from Lægemiddelstyrelsen’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

Provenance

Organization
Lægemiddelstyrelsen — imported from official source
Official source
https://laegemiddelstyrelsen.dk/da/Feeds/rss-feed/ RSS
Imported
October 30, 2026 15:32
Versions
1 recorded
Identity
4FA3C45C22004EA3A6651416FEFD17F4

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.